Sol-Gel Technologies/$SLGL
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Sol-Gel Technologies
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.
Ticker
$SLGL
Sector
Primary listing
Employees
28
Headquarters
Ness Ziona, Israel
Website
SLGL Metrics
BasicAdvanced
$242m
-
-$0.37
1.13
-
Price and volume
Market cap
$242m
Beta
1.13
52-week high
$97.97
52-week low
$6.96
Average daily volume
37k
Financial strength
Current ratio
8.837
Quick ratio
8.537
Long term debt to equity
0.733
Total debt to equity
1.677
Profitability
EBITDA (TTM)
-2.3
Gross margin (TTM)
9.30%
Net profit margin (TTM)
-5.66%
Operating margin (TTM)
-12.88%
Revenue per employee (TTM)
$660,000
Management effectiveness
Return on assets (TTM)
-3.47%
Return on equity (TTM)
-2.92%
Valuation
Price to revenue (TTM)
11.237
Price to book
4.71
Price to tangible book (TTM)
4.71
Growth
Revenue change (TTM)
52.57%
Earnings per share change (TTM)
-92.02%
3-year revenue growth (CAGR)
58.49%
3-year earnings per share growth (CAGR)
-64.50%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs